Playground build: anything marked “Sample data” is fictional.
Senate roll call 103, 119th Congress, 2nd session
S.Con.Res. 33: To establish a deficit-neutral reserve fund relating to requiring the Comptroller General of the United States to conduct a study related to economic consequences of private or confidential drug pricing agreements struck by any Federal department, agency, or office with any pharmaceutical manufacturer.
A to Z by last name within each position. Party, state and district as of the day of the vote.
None.
Source: Voteview (UCLA), from the Senate’s official record. Each senator’s position is checked against the roll call’s yea and nay totals. Members not listed weren’t serving that day. Built Nov 2, 2026. How we build these pages.